Abiopharma

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance

Gilead - Gilead’s Livdelzi® (Seladelpar) Delivers Statistically Significant Composite ALP Normalization in Phase 3 IDEAL Trial in Primary Biliary Cholangitis (PBC)

Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Financial Statements Q1 2026 Investor Presentation

NICE Actimize X-Sight Enterprise Cloud Solutions Selected by DNB Norway to Transform its Fraud and Financial Crime Operations

AVAX One Announces Update on Share Repurchase Program

Braiin Targets US$3 Trillion Global Residential Services Market Through ClearBank Embedded Banking Infrastructure Integrated into Home.cc Via Strategic Collaboration